Skip to content
Screener

McKesson MCK Q3 2026 earnings

Reported February 4, 2026 · After market close

Revenue$106.16BBeat by $362.8M
EPS$9.34Beat by $0.17
Revenue estimate$105.80B
EPS estimate$9.17

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$109.91B
EPS estimate$10.72

Financials

Q3 2026

Income statement

See full
Revenue$106.16B+11.4%
Gross profit$3.7B+12.2%
Operating income$1.6B+32.3%
Net income$1.2B+34.9%
EPS (diluted)$9.59+38.0%

Balance sheet

See full
Cash & equivalents$3.1B+138%
Total debt$9.8B+0.3%
Total equity-$1.3B+57.9%
Total assets$84.2B+18.4%

Cash flow

See full
Operating cash flow$1.2B+152%
CapEx$108.0M-14.3%
Free cash flow$1.1B+145%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$101.25B+39.9%
Enterprise value$107.99B+33.6%
P/E23.3×-2.3×
P/S0.3×0.0×

Profitability

See full
Gross margin3.6%-0.3pp
Operating margin1.4%+0.2pp
Net margin1.1%+0.3pp
FCF margin2.5%+2.0pp

Returns & leverage

See full
Current ratio0.9×0.0×

Segments

By segment

See full
North American Pharmaceutical$88.3B—
Oncology & Multispecialty$13.0B—
Medical-Surgical Solutions$3.0B+1.4%
Prescription Technology Solutions$1.5B+9.4%

FAQ

When did McKesson report Q3 2026 earnings?
McKesson (MCK) reported Q3 2026 earnings on February 4, 2026 after market close.
What were McKesson's Q3 2026 revenue and EPS?
McKesson reported revenue of $106.16B and eps of $9.34 for Q3 2026.
Did McKesson beat estimates in Q3 2026?
Revenue beat the consensus estimate of $105.80B by $362.8M. EPS beat the consensus estimate of $9.17 by $0.17.
How did McKesson's Q3 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 11.4% from $95.3B a year earlier and eps grew 16.3% from $8.03.
Where can I find McKesson's Q3 2026 SEC filings?
You can read the 8-K earnings release (0000927653-26-000015) and the 10-Q periodic report (0000927653-26-000017) directly on SEC EDGAR. The filing index links above go to sec.gov.